141 related articles for article (PubMed ID: 24915825)
1. [Progress of research on breast cancer stem cell markers].
Liu X; Li W; Fu L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
[No Abstract] [Full Text] [Related]
2. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells and radiotherapy: new insights into tumor radioresistance.
Diehn M; Clarke MF
J Natl Cancer Inst; 2006 Dec; 98(24):1755-7. PubMed ID: 17179471
[No Abstract] [Full Text] [Related]
5. Human breast and melanoma cancer stem cells biomarkers.
La Porta CA; Zapperi S
Cancer Lett; 2013 Sep; 338(1):69-73. PubMed ID: 22445909
[TBL] [Abstract][Full Text] [Related]
6. [An update: stem cell and cancer stem cells].
Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
[No Abstract] [Full Text] [Related]
7. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?
Habib M; Saif MW
JOP; 2013 Jul; 14(4):401-4. PubMed ID: 23846937
[TBL] [Abstract][Full Text] [Related]
12. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
Wang M; Xiao J; Jiang J; Qin R
Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
[No Abstract] [Full Text] [Related]
13. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
Roudi R; Korourian A; Shariftabrizi A; Madjd Z
Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
[TBL] [Abstract][Full Text] [Related]
15. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
17. [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
Lu ZH; Jia J; Ren J; Ma B; DI LJ; Song GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):480-5. PubMed ID: 18931709
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
Ayub TH; Keyver-Paik MD; Debald M; Rostamzadeh B; Thiesler T; Schröder L; Barchet W; Abramian A; Kaiser C; Kristiansen G; Kuhn W; Kübler K
Oncotarget; 2015 Jun; 6(18):16437-48. PubMed ID: 25999351
[TBL] [Abstract][Full Text] [Related]
20. Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.
DA Cruz Paula A; Lopes C
Anticancer Res; 2017 May; 37(5):2173-2183. PubMed ID: 28476780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]